Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion

被引:218
作者
Chan, HLY
Hussain, M
Lok, ASF
机构
[1] Univ Michigan, Med Ctr, Taubman Ctr 3912, Div Gastroenterol, Ann Arbor, MI 48109 USA
[2] Vet Adm Med Ctr, Ann Arbor, MI 48105 USA
关键词
D O I
10.1002/hep.510290352
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mutations in the core promoter and precore regions are frequently found in hepatitis B e antigen (HBeAg)-negative patients, but precore stop codon mutation is restricted to hepatitis B virus (HBV) genotypes that have T at nucleotide 1858, The aims of this study were to determine the role of core promoter and/or precore mutations in HBeAg seroconversion and their impact on the subsequent course of liver disease, and to determine if core promoter mutations are more frequently selected in patients with HBV genotypes that preclude the development of precore stop codon mutation. Serial sera from 45 patients with chronic HBV infection were polymerase chain reaction (PCR)-amplified, and the HBV core promoter and precore regions were sequenced. Ninety-two percent of patients had core promoter or precore mutations after HBeAg seroconversion: 42% had core promoter changes only, 38% had precore stop codon mutations only, and 12% had changes in both regions. Seventy-three percent of the patients had persistently normal aminotransferases, and only 8% had multiple flares in aminotransferases after HBeAg seroconversion, Core promoter changes were significantly more common in patients infected with HBV who have C at nucleotide 1858 (91% vs, 27%; P <.01), while precore stop codon changes were exclusively found in patients infected with HBV who have T at nucleotide 1858 (87% vs. 0; P <.01), The vast majority of our patients had core promoter and/or precore mutations after HBeAg seroconversion. Nevertheless, most patients had sustained remission of liver disease. Our data suggest that core promoter changes are preferentially selected in patients infected with HBV genotypes that preclude the development of precore stop codon mutation.
引用
收藏
页码:976 / 984
页数:9
相关论文
共 30 条
  • [1] CHRONIC ACTIVE HEPATITIS WITH HEPATITIS-B VIRUS-DNA AND ANTIBODY AGAINST E-ANTIGEN IN THE SERUM - DISTURBED SYNTHESIS AND SECRETION OF E-ANTIGEN FROM HEPATOCYTES DUE TO A POINT MUTATION IN THE PRECORE REGION
    AKAHANE, Y
    YAMANAKA, T
    SUZUKI, H
    SUGAI, Y
    TSUDA, F
    YOTSUMOTO, S
    OMI, S
    OKAMOTO, H
    MIYAKAWA, Y
    MAYUMI, M
    [J]. GASTROENTEROLOGY, 1990, 99 (04) : 1113 - 1119
  • [2] AKARCA US, 1994, HEPATOLOGY, V19, P1366
  • [3] WILD-TYPE AND E-ANTIGEN-MINUS HEPATITIS-B VIRUSES AND COURSE OF CHRONIC HEPATITIS
    BRUNETTO, MR
    GIARIN, MM
    OLIVERI, F
    CHIABERGE, E
    BALDI, M
    ALFARANO, A
    SERRA, A
    SARACCO, G
    VERME, G
    WILL, H
    BONINO, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) : 4186 - 4190
  • [4] Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication
    Buckwold, VE
    Xu, ZC
    Chen, M
    Yen, TSB
    Ou, JH
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (09) : 5845 - 5851
  • [5] Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication
    Buckwold, VE
    Xu, ZC
    Yen, TSB
    Ou, JH
    [J]. JOURNAL OF GENERAL VIROLOGY, 1997, 78 : 2055 - 2065
  • [6] CARMAN WF, 1989, LANCET, V2, P588
  • [7] Günther S, 1998, J GEN VIROL, V79, P375
  • [8] CHANGES IN THE PREVALENCE OF HBEAG-NEGATIVE MUTANT HEPATITIS-B VIRUS DURING THE COURSE OF CHRONIC HEPATITIS-B
    HAMASAKI, K
    NAKATA, K
    NAGAYAMA, Y
    OHTSURU, A
    DAIKOKU, M
    TANIGUCHI, K
    TSUTSUMI, T
    SATO, Y
    KATO, Y
    NAGATAKI, S
    [J]. HEPATOLOGY, 1994, 20 (01) : 8 - 14
  • [9] DIFFERENCES IN THE ENTIRE NUCLEOTIDE-SEQUENCE BETWEEN HEPATITIS-B VIRUS GENOMES FROM CARRIERS POSITIVE FOR ANTIBODY TO HEPATITIS-B E-ANTIGEN WITH AND WITHOUT ACTIVE DISEASE
    HORIKITA, M
    ITOH, S
    YAMAMOTO, K
    SHIBAYAMA, T
    TSUDA, F
    OKAMOTO, H
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (01) : 96 - 103
  • [10] A revised secondary structure model for the 3'-end of hepatitis B virus pregenomic RNA
    Kidd, AH
    KiddLjunggren, K
    [J]. NUCLEIC ACIDS RESEARCH, 1996, 24 (17) : 3295 - 3301